Home » MIVT Receives Grant to Expedite Development of HAp Stent Coating
MIVT Receives Grant to Expedite Development of HAp Stent Coating
MIV Therapeutics (MIVT) announced that its wholly owned subsidiary, MIVI Technologies -- which is involved in the research and development of multilayer coating technologies with drug eluting capability for cardiovascular stents and other implantable devices -- has received a government grant for the research program titled, "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents."
TMCnet.com (http://www.tmcnet.com/usubmit/2005/Mar/1127548.htm)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May